TGFB1 and type 2 diabetes mellitus: To explore the relationship between puerarin and PPAR-γ, we used exogenous PPAR-γ agonist, pioglitazone (Pio), a drug used to treat type 2 diabetes mellitus, to pretreat HUVECs before the intervention of TGF-β1.